NLVP

New Leaf Venture Partners Portfolio holdings

AUM $52.9M
This Quarter Return
+7.82%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$550M
AUM Growth
+$550M
Cap. Flow
+$124M
Cap. Flow %
22.52%
Top 10 Hldgs %
91.76%
Holding
21
New
6
Increased
3
Reduced
2
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DCPH
1
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$159M 28.92% 4,104,140
APTX
2
DELISTED
Aptinyx Inc. Common Stock
APTX
$95.3M 17.34% 3,290,079
PRNB
3
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$76.7M 13.96% +2,625,713 New +$76.7M
STIM icon
4
Neuronetics
STIM
$220M
$49.5M 9% 1,543,115
ARVN icon
5
Arvinas
ARVN
$568M
$38.5M 7.01% +2,283,048 New +$38.5M
WVE icon
6
Wave Life Sciences
WVE
$1.53B
$21.3M 3.87% 425,429 -8,000 -2% -$400K
CRSP icon
7
CRISPR Therapeutics
CRSP
$4.71B
$19.7M 3.59% 444,708
COGT icon
8
Cogent Biosciences
COGT
$1.69B
$18.5M 3.37% 1,795,545
OBSV
9
DELISTED
ObsEva SA Ordinary Shares
OBSV
$16.2M 2.95% 900,501 +10,000 +1% +$180K
ITRM icon
10
Iterum Therapeutics
ITRM
$30.2M
$9.65M 1.76% 1,456,303
TECX
11
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$8.94M 1.63% 172,350 +22,350 +15% +$1.16M
SRRA
12
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$8.54M 1.55% 5,020,446
AFMD
13
DELISTED
Affimed
AFMD
$7.83M 1.42% 1,800,000 -450,000 -20% -$1.96M
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$2.92B
$4.81M 0.87% +167,700 New +$4.81M
CMRX
15
DELISTED
Chimerix, Inc.
CMRX
$3.89M 0.71% +1,000,000 New +$3.89M
ARAV
16
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.47M 0.63% 2,478,400 +231,400 +10% +$324K
TARA icon
17
Protara Therapeutics
TARA
$120M
$2.93M 0.53% +1,500,000 New +$2.93M
PDSB icon
18
PDS Biotechnology
PDSB
$57.8M
$1.92M 0.35% 2,344,868
NERV icon
19
Minerva Neurosciences
NERV
$16.5M
$1.63M 0.3% +130,000 New +$1.63M
AVEO
20
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.33M 0.24% 402,118
OXFD
21
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-311,660 Closed -$4.02M